CSI Market
Sign In | Register

Royalty Pharma Plc (RPRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access RPRX quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Royalty Pharma Plc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent618.70
Available-for-sale Securities, Debt Securities, Current MA18.80
Cash & Short-term Investments636.00
Notes, Loans and Financing Receivable, Net, Current AC854.39
Other Current Assets36.21
Total Current Assets1,528.09
Goodwill net924.63
Intangible Assets0.00
Long-term investments419.00
Notes, Loans and Financing Receivable, Net, Noncurrent LO16,208.48
Other Assets, Noncurrent959.57
Accrued Royalty Receivable-
Other Royalty Income Receivable Current29.32
Equity Securities F V N I Noncurrent171.31
Total Assets19,620.78
Liabilities
Accounts Payable and Accrued Liabilities, Current LI19.40
Interest Payable, Current IN110.82
Long-term Debt, Current Maturities LO380.00
Other Liabilities, Current125.99
Total Current Liabilities636.21
Long-term debt8,570.92
Total Long-term Debt8,570.92
Due to Employees, Noncurrent698.71
Distributions Payable To Legacy Non Controlling Interests Current-
Total Liabilities9,905.84
Stockholders' Equity
Common Stock Value0.04
Treasury Stock Value0.00
Additional Paid In Capital Common Stock4,123.09
Retained Earnings / Accumulated Deficit2,356.32
Other Equity-2.55
Common Stockholder's Equity6,476.90
Non-controlling interests & other3,238.04
Total Stockholder's Equity9,714.94
Liabilities & Stockholder's Equity19,620.78
4 historic quarters locked

Sign in to unlock the full Royalty Pharma Plc balance sheet history.

Sign In Create Free Account

About Royalty Pharma Plc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 11, 2026
  • Source: rprx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001802768-26-000003

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.